Evidence map›Paper›PMID 21584845›Full record

ArticlePharmaceutical research2011

Turbidity spectroscopy for characterization of submicroscopic drug carriers, such as nanoparticles and lipid vesicles: size determination.

Mustafa M A Elsayed, Gregor Cevc

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. High-ResolutionBiochemistry · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mustafa M A ElsayedIDEA AG, Frankfurter Ring 193a, 80807 Munich, Germany. mmaelsayed@gmail.com
Gregor Cevc
Individual Development and Adaptive Education · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo apply UV/Vis spectrometry for characterization of submicroscopic drug carriers, such as nanoparticles and lipid vesicles.

methodsWe first investigated theoretically, within the framework of the Rayleigh-Gans-Debye approximation (RGDA), parameters affecting turbidity spectrum, τ(λ), of nanosized light scatterers. We then analyzed, within the framework of the RGDA, experimental turbidity spectra (λ = 400-600 nm) of extruded unilamellar vesicle (70 nm ≤ 2r ≤ 110 nm) suspensions to derive vesicle size, using dynamic light scattering results for comparison. We similarly studied the preparations polydispersity and lamellarity and monitored vesicle size changes.

resultsTurbidimetry suffices for accurate, fast, and viscosity-independent characterization of submicroscopic particles. Analysis of turbidity spectra, or more precisely wavelength exponent spectra (derivatives of logarithmic turbidity spectra), yielded similar average radii (r = 54.2 ± 0.2 nm; 46.0 ± 0.2 nm; 35.5 ± 0.1 nm) as dynamic light scattering (r = 55.9 ± 1.5 nm; 46.1 ± 0.4 nm; 36.1 ± 0.4 nm). Both methods also revealed similar suspension polydispersity and cholate-induced vesicle size changes in a few nanometer range.

conclusionDespite its experimental simplicity, the widely accessible turbidimetric method provides accurate size values and is suitable for (continuous) monitoring size stability, or sameness, of submicroscopic drug carriers.

Indexed as

Models, TheoreticalParticle SizeDrug CarriersLightLipid BilayersNanoparticlesNephelometry and TurbidimetryPhosphatidylcholinesScattering, RadiationSpectrophotometry, UltravioletUnilamellar LiposomesDrug CarriersLipid BilayersPhosphatidylcholinesUnilamellar Liposomes

Identifiers

PMID21584845
OpenAlexW1997103904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.